Company: NCEL
Filing Date: 2025-09-25
Form Type: F-1
Source: 0001213900-25-091697
Chunk: 0

Company: NewcelX Ltd.
Filing Date: 2025-09-25
Form: F-1
Chunk 0
---
<div align='center'>As filed with the Securities and Exchange Commission on September 25, 2025</div>

Registration No. 333-

<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

Form F-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

NLS PHARMACEUTICS LTD.

(Exact name of registrant as specified in its charter)</div>

| Switzerland                     |     |                         3841 |     | Not Applicable        |
| (State or other jurisdiction of 
 incorporation or organization)  |     | -Primary Standard Industrial 
   Classification Code Number |     | -I.R.S. Employer      
 Identification Number |

| The Circle 6                                                      |     | Puglisi & Associates                                      |
| 8058 Zurich, Switzerland                                          |     | 850 Library Ave., Suite 204, Newark, DE 19711             |
| Tel: +41.44.512.2150                                              |     | Tel: (302) 738-6680                                       |
| (Address, including zip code, and telephone number,               |     | (Name, address, including zip code, and telephone number, |
| including area code, of registrant’s principal executive offices) |     | including area code, of agent for service)                |

<div align='center'>Copies to:</div>

| Oded Har-Even, Esq.         |     | Dr. Matthias Courvoisier      |
| Howard Berkenblit, Esq.     
 Ron Ben-Bassat, Esq.        
 Sullivan & Worcester LLP    
 1251 Avenue of the Americas 
 New York, NY 10020          
 Tel: 212.660.3000           |     | Baker McKenzie Switzerland AG 
 Holbeinstrasse 30             
 Zurich, Switzerland 8034      
 Tel: +41 44 384 14 14         |

Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date hereof.

If any of the securities being registered on this
form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, check the following box. ☒

If this form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier